Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-25 @ 5:22 AM
Study NCT ID:
NCT00124020
Status:
COMPLETED
Last Update Posted:
2019-01-16
First Post:
2005-07-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
Sponsor:
Cumberland Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Steven L. Barriere, Pharm.D., Vice President, Clinical and Medical Affairs
Old Organization:
Theravance, Inc.